Literature DB >> 15311344

Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.

Gianfranco Spalletta1, Francesca Baldinetti, Ivana Buccione, Lucia Fadda, Roberta Perri, Silvia Scalmana, Laura Serra, Carlo Caltagirone.   

Abstract

Clinical expressions of cognition and behaviour in Alzheimer's disease (AD) patients are heterogeneous. Therefore, assessing the entire range of selective cognitive and behavioural characteristics of dementia in minute detail is extremely important. However, considering that groups of different symptoms may respond to the same pharmacological agent, it is also evident that a correct evaluation of the behaviour requires the grouping of symptoms in fewer syndromes. Thus, the authors have analysed various connections between selective cognitive domains and behavioural symptoms (BPSD) in probable AD outpatients. Two hundred and forty four patients with diagnosis of probable AD, according to DSM-IV and NINCDS-ADRDA criteria were enrolled. The evaluation included the Mini Mental State Examination, the Mental Deterioration Battery, and the Neuropsychiatric Inventory. Treatment with low doses of neuroleptic drugs only was allowed. Principal component analysis condensed the 18 cognitive/behavioural variables in 7 factors namely general-cognitive, constructional abilities, hyperactivity, psychosis, anxiety, mood-excitement and mood-depression/apathy. None of the cognitive domains were included in the behavioural factors and vice-versa. Furthermore, the only BPSD which impaired continuously with progression of disease severity was apathy which was also the most severe symptom. In conclusion, many cognitive and behavioural syndromes exist in patients with AD. However, the results of this study suggest that cognition and behaviour are independent dimensions.

Entities:  

Mesh:

Year:  2004        PMID: 15311344     DOI: 10.1007/s00415-004-0403-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease.

Authors:  Paola Bossù; Antonio Ciaramella; Maria Luisa Moro; Lorenza Bellincampi; Sergio Bernardini; Giorgio Federici; Alberto Trequattrini; Fabio Macciardi; Ilaria Spoletini; Fulvia Di Iulio; Carlo Caltagirone; Gianfranco Spalletta
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

2.  Behavioral and psychological symptoms of dementia and their management.

Authors:  Nilamadhab Kar
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

3.  Voxel-based morphometry findings in Alzheimer's disease: neuropsychiatric symptoms and disability correlations - preliminary results.

Authors:  Luciano de Gois Vasconcelos; Andrea Parolin Jackowski; Maira Okada de Oliveira; Yoná Mayara Ribeiro Flor; Orlando Francisco Amodeo Bueno; Sonia Maria Dozzi Brucki
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

Review 5.  Frontotemporal dementia to Alzheimer's disease.

Authors:  Maria Caterina Silveri
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 6.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

7.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  Missing data analysis in drug-naïve Alzheimer's disease with behavioral and psychological symptoms.

Authors:  Yong Tae Kwak; YoungSoon Yang; Sang-Gue Park
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

9.  Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Susanna Pietropaolo; Joram Feldon; Benjamin K Yee
Journal:  Cogn Affect Behav Neurosci       Date:  2014-09       Impact factor: 3.526

Review 10.  The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders.

Authors:  Claudia K Y Lai
Journal:  Clin Interv Aging       Date:  2014-07-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.